Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

45.22
+0.56001.25%
Post-market: 44.94-0.2800-0.62%16:55 EDT
Volume:2.93M
Turnover:132.39M
Market Cap:3.60B
PE:-12.04
High:45.92
Open:44.28
Low:43.91
Close:44.66
Loading ...

BRIEF-Akero Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
29 Jan

Akero Therapeutics Inc - Prices Upsized Public Offering of 5.33 Mln Shares at $48/Share

THOMSON REUTERS
·
29 Jan

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
29 Jan

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
29 Jan

Stock Track | Akero Therapeutics Soars Nearly 8% Premarket on Promising NASH Drug Data, Analyst Optimism

Stock Track
·
28 Jan

Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday

MT Newswires Live
·
28 Jan

Stock Track | Akero Therapeutics Soars 5.82% Pre-Market on Analyst Optimism for Efruxifermin Drug Candidate

Stock Track
·
28 Jan

Why Akero Therapeutics Inc. (AKRO) Surged on Monday

Insider Monkey
·
28 Jan

Akero Therapeutics’ Efruxifermin Shows Promise: Buy Rating Backed by Upcoming SYMMETRY Data and Potential Stock Upside

TIPRANKS
·
28 Jan

Akero Therapeutics price target raised to $96 from $46 at Morgan Stanley

TIPRANKS
·
28 Jan

Akero Therapeutics: Promising SYMMETRY Trial Results Position Efruxifermin for Market Success

TIPRANKS
·
28 Jan

Akero Therapeutics Is Maintained at Buy by Citigroup

Dow Jones
·
28 Jan

Akero Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
28 Jan

Akero Therapeutics Inc : Morgan Stanley Raises Target Price to $96.00 From $46.00

THOMSON REUTERS
·
28 Jan

U.S. RESEARCH ROUNDUP-Akero Therapeutics, Coca-Cola, Mastec

Reuters
·
28 Jan

Akero Therapeutics Starts $300 Million Stock Offering

MT Newswires Live
·
28 Jan